[Long-term treatment with cabergoline in pregnancy and neonatal outcome: report of a clinical case].
Hyperprolactinemia is one of the causes of sterility. Cabergoline is indicated in cases resistant to bromocriptine, but, usually, its administration is interrupted at the beginning of the pregnancy. A case of prolonged treatment with cabergoline during pregnancy is reported, without teratogenic effects on the fetus.